MedPath

Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers

Phase 4
Terminated
Conditions
Atrial Fibrillation
Interventions
Drug: Placebo (for Dronedarone)
Registration Number
NCT01135017
Lead Sponsor
Sanofi
Brief Summary

Primary objective was to evaluate the effects of dronedarone on Atrial Fibrillation (AF) burden (i.e. percent time in AF) as measured on electrogram (EGM) in subjects with a permanent pacemaker.

Secondary objectives were to evaluate:

* the effects of dronedarone on AF pattern characteristics i.e. ventricular rate during AF;

* the effects of dronedarone on subject-perceived AF burden and symptom severity as reported by subjects using the Atrial Fibrillation Severity Scale (AFSS);

* the incidence of electrical cardioversion (or overdrive pacing) during treatment;

* the safety of dronedarone.

Detailed Description

The maximum duration of the study period for a participant was 18 weeks (approximatively 4.5 months) including up to 4 weeks screening, 12-week Treatment period and a post-treatment follow-up of 2 weeks.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
112
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
DronedaroneDronedaroneDronedarone 400 mg twice a day for 12 weeks
PlaceboPlacebo (for Dronedarone)Placebo (for Dronedarone) twice a day for 12 weeks
Primary Outcome Measures
NameTimeMethod
Atrial Fibrillation (AF) Burden During the 12-week Treatment PeriodBaseline (before randomization), 4 weeks and 12 weeks after randomization

AF burden, defined as the percent time a subject is in AF, was evaluated centrally by a Pacemaker Core Lab based on pacemaker interrogation reports including Electrogram (EGM) data provided by the Investigator.

AF burden during the 12-week treatment period was defined as the duration-weighted average of AF burden collected at Week 4 and Week 12. It was calculated from the single available measurement when one measurement was missing.

Secondary Outcome Measures
NameTimeMethod
AF Burden During the First 4 Weeks of Treatment and After 4-week Treatment4 weeks and 12 weeks after randomization

AF burden at each pacemaker interrogation as evaluated centrally by the Pacemaker Core Lab

Average Ventricular Rate During AF EpisodesBaseline (before randomization), 4 weeks and 12 weeks after randomization

Ventricular rates of AF episodes were obtained from pacemaker interrogation and EGM review.

The average ventricular rate during AF episodes in the 12-week treatment period was defined as the duration-weighted average of the ventricular rates collected at Week 4 and Week 12. It was calculated from the single available measurement when one measurement was missing.

Atrial Fibrillation Severity Scale (AFSS) ScoresBaseline (before randomization) and 12 weeks after randomization

The University of Toronto Atrial Fibrillation Severity Scale is an instrument to assess the subject-perceived AF burden and AF symptom severity. It consists in a questionnaire plus a scoring algorithm.

AF Burden score ranges from 3 to 30 and higher scores indicate greater AF burden.

AF symptoms severity score ranges from 0 to 35 and higher scores indicate extremely severe AF symptoms.

Incidence Rate of Electrical Cardioversion (or Overdrive Pacing)12 weeks

Electrical cardioversion is a procedure in which an electric shock is used to restore normal heart rhythm. Overdrive pacing is a procedure in which an artificial cardiac pacemaker is used to increase the heart rate in order to suppress certain arrhythmias.

Incidence rate of electrical cardioversion (or overdrive pacing) is expressed as the number of participants that was cardioverted or paced during the study.

Trial Locations

Locations (92)

Investigational Site Number 840021

🇺🇸

Riverside, California, United States

Investigational Site Number 840030

🇺🇸

Mesa, Arizona, United States

Investigational Site Number 840014

🇺🇸

Dallas, Texas, United States

Investigational Site Number 840105

🇺🇸

Pittsburgh, Pennsylvania, United States

Investigational Site Number 840029

🇺🇸

Loveland, Colorado, United States

Investigational Site Number 840089

🇺🇸

Littleton, Colorado, United States

Investigational Site Number 840027

🇺🇸

Troy, Michigan, United States

Investigational Site Number 840015

🇺🇸

Birmingham, Alabama, United States

Investigational Site Number 840024

🇺🇸

San Diego, California, United States

Investigational Site Number 840072

🇺🇸

Phoenix, Arizona, United States

Investigational Site Number 840012

🇺🇸

San Antonio, Texas, United States

Investigational Site Number 840083

🇺🇸

Salt Lake City, Utah, United States

Investigational Site Number 840033

🇺🇸

Milwaukee, Wisconsin, United States

Investigational Site Number 840076

🇺🇸

Milwaukee, Wisconsin, United States

Investigational Site Number 840001

🇺🇸

Aurora, Colorado, United States

Investigational Site Number 840042

🇺🇸

Orlando, Florida, United States

Investigational Site Number 840036

🇺🇸

Bronx, New York, United States

Investigational Site Number 840087

🇺🇸

Huntsville, Alabama, United States

Investigational Site Number 840018

🇺🇸

Mobile, Alabama, United States

Investigational Site Number 840013

🇺🇸

Tucson, Arizona, United States

Investigational Site Number 840048

🇺🇸

Phoenix, Arizona, United States

Investigational Site Number 840090

🇺🇸

Laguna Hills, California, United States

Investigational Site Number 840069

🇺🇸

Hot Springs, Arkansas, United States

Investigational Site Number 840070

🇺🇸

Orange, California, United States

Investigational Site Number 840121

🇺🇸

Beverly Hills, California, United States

Investigational Site Number 840068

🇺🇸

Los Angeles, California, United States

Investigational Site Number 840062

🇺🇸

Mission Hills, California, United States

Investigational Site Number 840108

🇺🇸

Newark, Delaware, United States

Investigational Site Number 840106

🇺🇸

Washington, District of Columbia, United States

Investigational Site Number 840045

🇺🇸

Washington, District of Columbia, United States

Investigational Site Number 840058

🇺🇸

Inverness, Florida, United States

Investigational Site Number 840020

🇺🇸

Ft. Myers, Florida, United States

Investigational Site Number 840044

🇺🇸

Jacksonville Beach, Florida, United States

Investigational Site Number 840066

🇺🇸

Jacksonville, Florida, United States

Investigational Site Number 840128

🇺🇸

Jacksonville, Florida, United States

Investigational Site Number 840010

🇺🇸

Clearwater, Florida, United States

Investigational Site Number 840043

🇺🇸

Jacksonville, Florida, United States

Investigational Site Number 840080

🇺🇸

Wellington, Florida, United States

Investigational Site Number 840092

🇺🇸

Normal, Illinois, United States

Investigational Site Number 840016

🇺🇸

Port Charlotte, Florida, United States

Investigational Site Number 840051

🇺🇸

Bloomington, Indiana, United States

Investigational Site Number 840056

🇺🇸

Gainesville, Georgia, United States

Investigational Site Number 840053

🇺🇸

Kansas City, Kansas, United States

Investigational Site Number 840032

🇺🇸

Oak Lawn, Illinois, United States

Investigational Site Number 840110

🇺🇸

Owensboro, Kentucky, United States

Investigational Site Number 840046

🇺🇸

Rockford, Illinois, United States

Investigational Site Number 840102

🇺🇸

Columbia, Maryland, United States

Investigational Site Number 840017

🇺🇸

Lansing, Michigan, United States

Investigational Site Number 840081

🇺🇸

Lapeer, Michigan, United States

Investigational Site Number 840075

🇺🇸

Petoskey, Michigan, United States

Investigational Site Number 840097

🇺🇸

Tupelo, Mississippi, United States

Investigational Site Number 840104

🇺🇸

St Cloud, Minnesota, United States

Investigational Site Number 840055

🇺🇸

St. Louis, Missouri, United States

Investigational Site Number 840037

🇺🇸

Columbia, Missouri, United States

Investigational Site Number 840060

🇺🇸

St Louis, Missouri, United States

Investigational Site Number 840067

🇺🇸

Missoula, Montana, United States

Investigational Site Number 840049

🇺🇸

Reno, Nevada, United States

Investigational Site Number 840026

🇺🇸

Bridgewater, New Jersey, United States

Investigational Site Number 840054

🇺🇸

Reno, Nevada, United States

Investigational Site Number 840093

🇺🇸

Englewood, New Jersey, United States

Investigational Site Number 840086

🇺🇸

Troy, New York, United States

Investigational Site Number 840077

🇺🇸

Kingston, New York, United States

Investigational Site Number 840096

🇺🇸

Mineola, New York, United States

Investigational Site Number 840006

🇺🇸

Buffalo, New York, United States

Investigational Site Number 840041

🇺🇸

Syracuse, New York, United States

Investigational Site Number 840065

🇺🇸

Tulsa, Oklahoma, United States

Investigational Site Number 840084

🇺🇸

Raleigh, North Carolina, United States

Investigational Site Number 840007

🇺🇸

Williamsville, New York, United States

Investigational Site Number 840061

🇺🇸

Wilmington, North Carolina, United States

Investigational Site Number 840008

🇺🇸

Camp Hill, Pennsylvania, United States

Investigational Site Number 840004

🇺🇸

Philadelphia, Pennsylvania, United States

Investigational Site Number 840078

🇺🇸

Phoenixville, Pennsylvania, United States

Investigational Site Number 840009

🇺🇸

Doylestown, Pennsylvania, United States

Investigational Site Number 840019

🇺🇸

Unionville, Pennsylvania, United States

Investigational Site Number 840002

🇺🇸

Rapid City, South Dakota, United States

Investigational Site Number 840130

🇺🇸

Scranton, Pennsylvania, United States

Investigational Site Number 840119

🇺🇸

Greenville, South Carolina, United States

Investigational Site Number 840023

🇺🇸

Wyomissing, Pennsylvania, United States

Investigational Site Number 840114

🇺🇸

Germantown, Tennessee, United States

Investigational Site Number 840118

🇺🇸

Corpus Christi, Texas, United States

Investigational Site Number 840125

🇺🇸

Tyler, Texas, United States

Investigational Site Number 840113

🇺🇸

Danville, Virginia, United States

Investigational Site Number 840082

🇺🇸

Lynchburg, Virginia, United States

Investigational Site Number 840088

🇺🇸

Manassas, Virginia, United States

Investigational Site Number 840003

🇺🇸

Tacoma, Washington, United States

Investigational Site Number 840107

🇺🇸

Tacoma, Washington, United States

Investigational Site Number 840123

🇺🇸

Green Bay, Wisconsin, United States

Investigational Site Number 840047

🇺🇸

Milwaukee, Wisconsin, United States

Investigational Site Number 840035

🇺🇸

Kansas City, Missouri, United States

Investigational Site Number 840099

🇺🇸

Richmond, Virginia, United States

Investigational Site Number 840112

🇺🇸

Richmond, Virginia, United States

Investigational Site Number 840022

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath